Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients With X-linked Hypophosphatemia
A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
X-linked Hypophosphatemia
Kyowa Kirin Co., Ltd.NCT06525636
Phase 2
Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients
The primary goal is to determine if Dipyridamole can improve serum phosphate levels and reduce the need for phosphate supplementation.
HypophosphatemiaKidney Transplantation
Stanford UniversityNCT06824454